Immunology of Crohn's disease

Annals of the New York Academy of Sciences

Volumn 1072, Issue , 2006, Pages 135-154

  Braat, Henri ^a   Peppelenbosch, Maikel P ^b   Hommes, Daan W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Crohn's disease; Dendritic cells; Mucosal immunology; Pattern recognition and host bacterial cells

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREDNISONE;

BACTERIAL CELL; CONFERENCE PAPER; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTESTINE MUCOSA PERMEABILITY; NONHUMAN;

BACTERIA (MICROORGANISMS);

EID: 33748992048     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1326.039     Document Type: Conference Paper

References (121)

1. SANDBORN, W., L. SUTHERLAND, D. PEARSON, et al. 2000. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst. Rev: CD000545.
2. ALFADHLI, A.A., J.W. MCDONALD & B.G. FEAGAN. 2003. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst. Rev: CD003459.
3. CROHN, B.B., L. GINZBURG & G.D. OPPENHEIMER. 1952. Regional ileitis: a pathologic and clinical entity. Am. J. Med. 13: 583-590.
4. BOUMA, G. & W. STROBER. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533.
5. SONWALKAR, S.A., R.M. JAMES, T. AHMAD, et al. 2003. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 52: 1518-1521.
6. MACPHERSON, A.J., D. GATTO, E. SAINSBURY, et al. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288: 2222-2226.
7. GANZ, T. 2003. Microbiology: gut defence. Nature 422: 478-479.
8. BARTON, G.M. & R. MEDZHITOV. 2002. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270: 81-92.
9. JANEWAY, C.A. JR. & R. MEDZHITOV. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
10. JIANG, Q., S. AKASHI, K. MIYAKE, et al. 2000. Cutting edge: lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-{kappa}B. J. Immunol. 165: 3541-3544.
11. CHOW, J.C., D.W. YOUNG, D.T. GOLENBOCK, et al. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274: 10689-10692.
12. PALSSON-MCDERMOTT, E.M. & L.A. O'NEILL. 2004. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 113: 153-162.
13. SANDOR, F., E. LATZ, F. RE, et al. 2003. Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling. J. Cell. Biol. 162: 1099-1110.
14. VAN DER KLEIJ, D., E. LATZ, J.F. BROUWERS, et al. 2002. A novel host-parasite lipid cross-talk: schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277: 48122-48129.
15. MEANS, T.K., E. LIEN, A. YOSHIMURA, et al. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for toll-like receptors. J. Immunol. 163: 6748-6755.
16. NAKAO, Y., K. FUNAMI, S. KIKKAWA, et al. 2005. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J. Immunol. 174: 1566-1573.
17. BUWITT-BECKMANN, U., H. HEINE, K.H. WIESMULLER, et al. 2005. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol. 35: 282-289.
18. GANTNER, B.N., R.M. SIMMONS, S.J. CANAVERA, et al. 2003. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J. Exp. Med. 197: 1107-1117.
19. HAJJAR, A.M., D.S. O'MAHONY, A. OZINSKY, et al. 2001. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166: 15-19.
20. OZINSKY, A., D.M. UNDERHILL, J.D. FONTENOT, et al. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766-13771.
21. FUJITA, M., T. INTO, M. YASUDA, et al. 2003. Involvement of leucine residues at positions 107, 112, and 115 in a leucine-rich repeat motif of human toll-like receptor 2 in the recognition of diacylated lipoproteins and lipopeptides and Staphylococcus aureus peptidoglycans. J. Immunol. 171: 3675-3683.
22. ALEXOPOULOU, L., A.C. HOLT, R. MEDZHITOV, et al. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413: 732-738.
23. FLO, T.H., L. RYAN, E. LATZ, et al. 2002. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem. 277: 35489-35495.
24. YANG, S., S. SUGAWARA, T. MONODANE, et al. 2001. Micrococcus luteus teichuronic acids activate human and murine monocytic cells in a CD14- and toll-like receptor 4-dependent manner. Infect. Immun. 69: 2025-2030.
25. SHOHAM, S., C. HUANG, J.M. CHEN, et al. 2001. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166: 4620-4626.
26. ZAMZE, S., L. MARTINEZ-POMARES, H. JONES, et al. 2002. Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor. J. Biol. Chem. 277: 41613-41623.
27. SMITH, K.D., E. ANDERSEN-NISSEN, F. HAYASHI, et al. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4: 1247-1253.
28. LUND, J.M., L. ALEXOPOULOU, A. SATO, et al. 2004. Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603.
29. HEIL, F., H. HEMMI, H. HOCHREIN, et al. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
30. LATZ, E., A. SCHOENEMEYER, A. VISINTIN, et al. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5: 190-198.
31. BANCHEREAU, J. & R.M. STEINMAN. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
32. MOSER, M. & K.M. MURPHY. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1: 199-205.
33. WILSON, N.S., D. EL-SUKKARI, G.T. BELZ, et al. 2003. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102: 2187-2194.
34. CHOW, A., D. TOOMRE, W. GARRETT, et al. 2002. Dendritic cell maturation triggers retrograde MHC class 11 transport from lysosomes to the plasma membrane. Nature 418: 988-994.
35. KADOWAKI, N., S. HO, S. ANTONENKO, et al. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-870.
36. HUANG, Q., D. LIU, P. MAJEWSKI, et al. 2001. The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870-875.
37. LANZAVECCHIA, A. & F. SALLUSTO. 2000. From synapses to immunological memory: the role of sustained T cell stimulation. Curr. Opin. Immunol. 12: 92-98.
38. KAPSENBERG, M.L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
39. NIESS, J.H., S. BRAND, X. Gu, et al. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254-258.
40. MACPHERSON, A.J. & T. UHR. 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662-1665.
41. ALPAN, O., G. RUDOMEN & P. MATZINGER. 2001. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J. Immunol. 166: 4843-4852.
42. JOHANSSON-LINDBOM, B., M. SVENSSON, M.A. WURBEL, et al. 2003. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J. Exp. Med. 198: 963-969.
43. HUGOT, J.P., M. CHAMAILLARD, H. ZOUALI, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
44. FRANCHIMONT, D., S. VERMEIRE, H. EL HOUSNI, et al. 2004. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-992.
45. VERMEIRE, S., G. WILD, K. KOCHER, et al. 2002. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am. J. Hum. Genet. 71: 74-83.
46. TE VELDE, A., Y. VAN KOOYK, H. BRAAT, et al. 2003. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur. J. Immunol. 33: 143-151.
47. BECKER, C., S. WIRTZ, M. BLESSING, et al. 2003. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112: 693-706.
48. CAMOGLIO, L., A.A. TE VELDE, A.J. TIGGES, et al. 1998. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm. Bowel Dis. 4: 285-290.
49. PARRONCHI, P., P. ROMAGNANI, F. ANNUNZIATO, et al. 1997. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150: 823-832.
50. FUSS, I.J., M. NEURATH, M. BOIRIVANT, et al. 1996. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157: 1261-1270.
51. NEURATH, M.F., B. WEIGMANN, S. FINOTTO, et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195: 1129-1143.
52. IIJIMA, H., M.F. NEURATH, T. NAGAISHI, et al. 2004. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J. Exp. Med. 199: 471-482.
53. SIMPSON, S.J., S. SHAH, M. COMISKEY, et al. 1998. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J. Exp. Med. 187: 1225-1234.
54. WIRTZ, S., S. FINOTTO, S. KANZLER, et al. 1999. Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-preducing CD4+ T cells that respond to bacterial antigens. J. Immunol. 162: 1884-1888.
55. MULLEN, A.C., F.A. HIGH, A.S. HUTCHINS, et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292: 1907-1910.
56. AGNELLO, D., C.S. LANKFORD, J. BREAM, et al. 2003. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23: 147-161.
57. BLUESTONE, J.A. & A.K. ABBAS. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
58. ASSEMAN, C., S. READ & F. POWRIE. 2003. Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol. 171: 971-978.
59. MALOY, K.J., L. SALAUN, R. CAHILL, et al. 2003. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197: 111-119.
60. KHATTRI, R., T. COX, S.A. YASAYKO, et al. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4: 337-342.
61. FONTENOT, J.D., M.A. GAVIN & A.Y. RUDENSKY. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
62. GROUX, H., A. O'GARRA, M. BIGLER, et al. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
63. GONNELLA, P.A., Y. CHEN, J. INOBE, et al. 1998. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J. Immunol. 160: 4708-4718.
64. CHEN, Y, V.K. KUCHROO, J. INOBE, et al. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
65. HAMPE, J., A. CUTHBERT, P.J. CROUCHER, et al. 2001. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357: 1925-1928.
66. OGURA, Y., D.K. BONEN, N. INOHARA, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
67. INOHARA, N. & G. NUNEZ. 2001. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 20: 6473-6481.
68. OGURA, Y., N. INOHARA, A. BENITO, et al. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276: 4812-4818.
69. GUTIERREZ, O., C. PIPAON, N. INOHARA, et al. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 277: 41701-41705.
70. ROSENSTIEL, P., M. FANTINI, K. BRAUTIGAM, et al. 2003. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124: 1001-1009.
71. HISAMATSU, T., M. SUZUKI, H.C. REINECKER, et al. 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124: 993-1000.
72. OGURA, Y., S. LALA, W. XIN, et al. 2003. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52: 1591-1597.
73. LALA, S., Y. OGURA, C. OSBORNE, et al. 2003. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125: 47-57.
74. INOHARA, N., Y. OGURA, A. FONTALBA, et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J. Biol. Chem. 278: 5509-5512.
75. GIRARDIN, S.E., I.G. BONECA, J. VIALA, et al. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278: 8869-8872.
76. WATANABE, T., A. KITANI, P.J. MURRAY, et al. 2004. NOD2 is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5: 800-808.
77. KOBAYASHI, K.S., M. CHAMAILLARD, Y. OGURA, et al. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734.
78. MAEDA, S., L.C. HSU, H. LIU, et al. 2005. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307: 734-738.
79. ARBOUR, N.C., E. LORENZ, B.C. SCHUTTE, et al. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25: 187-191.
80. POLTORAK, A., X. HE, I. SMIRNOVA, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
81. HOSHINO, K., O. TAKEUCHI, T. KAWAI, et al. 1999. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
82. RUTGEERTS, P., K. GOBOES, M. PEETERS, et al. 1991. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338: 771-774.
83. D'HAENS, G.R., K. GEBOES, M. PEETERS, et al. 1998. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114: 262-261.
84. HARPER, P.H., E.G. LEE, M.G. KETTLEWELL, et al. 1985. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 26: 279-284.
85. SWIDSINSKI, A., A. LADHOFF, A. PERNTHALER, et al. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
86. GLASSER, A.L., J. BOUDEAU & N. BARNICH. 2001. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69: 5529-5537.
87. DARFEUILLE-MICHAUD, A., C. NEUT & N. BARNICH. 1998. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115: 1405-1413.
88. HOOPER, L.V., T. MIDTVEDT, & J.I. GORDON. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22: 283-307.
89. FALK, P.G., L.V. HOOPER, T. MIDTVEDT, et al. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62: 1157-1170.
90. TAGA, M.E. & B.L. BASSLER. 2003. Chemical communication among bacteria. Proc. Natl. Acad. Sci. USA 100: 14549-14554.
91. HENTZER, M. & M. GIVSKOV. 2003. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Invest. 112: 1300-1307.
92. SPAINK, H.P. 2002. Plant-microbe interactions: a receptor in symbiotic dialogue. Nature 417: 910-911.
93. KRUSELL, L., L.H. MADSEN, S. SATO, et al. 2002. Shoot control of root development and nodulation is mediated by a receptor-like kinase. Nature 420: 422-426.
94. MADSEN, E.B., L.H. MADSEN, S. RADUTOIU, et al. 2003. A receptor kinase gene of the LysM type is involved in legume perception of rhizobial signals. Nature 425: 637-640.
95. RADUTOIU, S., L.H. MADSEN, E.B. MADSEN, et al. 2003. Plant recognition of symbiotic bacteria requires two LysM receptor-like kinases. Nature 425: 585-592.
96. NISHIMURA, R., M. HAYASHI, G.J. WU, et al. 2002. HAR1 mediates systemic regulation of symbiotic organ development. Nature 420: 426-429.
97. HOOPER, L.V. & J.I. GORDON. 2001. Commensal host-bacterial relationships in the gut. Science 292: 1115-1118.
98. HOOPER, L.V., M.H. WONG, A. THELIN, et al. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884.
99. HOOPER, L.V., T.S. STAPPENBECK & C.V. HONG. 2003. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4: 269-273.
100. YAMANAKA, T., L. HELGELAND, I.N. FARSTAD, et al. 2003. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J. Immunol. 170: 816-822.
101. RHEE, K.J., P. SETHUPATHI, A. DRIKS, et al. 2004. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 172: 1118-1124.
102. KADO, S., K. UCHIDA, H. FUNABASHI, et al. 2001. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res. 61: 2395-2398.
103. SARTOR, R.B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
104. GUARNER, F. & G.J. SCHAAFSMA. 1998. Probiotics. Int. J. Food Microbiol. 39: 237-238.
105. FORESTIER, C., C. DE CHAMPS, C. VATOUX, et al. 2001. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 152: 167-173.
106. MACK, D.R., S. MICHAIL, S. WEI, et al. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276: G941-G950.
107. BANASAZ, M., E. NORIN, R. HOLMA, et al. 2002. Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 68: 3031-3034.
108. GARCIA-LAFUENTE, A., M. ANTOLIN, F. GUARNER, et al. 2001. Modulation of colonic barrier function by the composition of the commensal flora in the rat. Gut 48: 503-507.
109. KALLIOMAKI, M., S. SALMINEN, H. ARVILOMMI, et al. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
110. SCHIFFRIN, E.J., D. BRASSART, A.L. SERVIN, et al. 1997. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66: 515S-520S.
111. PRANTERA, C., M.L. SCRIBANO, G. FALASCO, et al. 2002. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51: 405-409.
112. GALAN, J.E. & J.B. BLISKA. 1996. Cross-talk between bacterial pathogens and their host cells. Annu. Rev. Cell. Dev. Biol. 12: 221-255.
113. HORNEF, M.W., M.J. WICK, M. RHEN, et al. 2002. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 3: 1033-1040.
114. CORNELIS, G.R. 2002. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell. Biol. 3: 742-752.
115. SING, A., D. ROST, N. TVARDOVSKAIA, et al. 2002. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196: 1017-1024.
116. SING, A., A. ROGGENKAMP, A.M. GEIGER, et al. 2002. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168: 1315-1321.
117. MILLS, K.H. 2001. Immunity to Bordetella pertussis. Microbes Infect. 3: 655-677.
118. MCGUIRK, P., C. MCCANN & K.H. MILLS. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195: 221-231.
119. HIGGINS, S.C., E.C. LAVELLE, C. MCCANN, et al. 2003. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171: 3119-3127.
120. STEIDLER, L., W. HANS, L. SCHOTTE, et al. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin- 10. Science 289: 1352-1355.
121. STEIDLER, L., S. NEIRYNCK, N. HUYGHEBAERT, et al. 2003. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21: 785-789.